TABLE 4.
Characteristics | Dominant-Negative Effect (n=187) | Haploinsufficiency (n=169) |
---|---|---|
Female, % | 51 | 61 |
ECG at enrollment | ||
QTc,* ms | 500±60 | 470±50 |
Therapy, % | ||
β-Blockers | 47 | 37 |
Pacemaker | 1.1 | 4.1 |
Sympathectomy | 0.5 | 0 |
Defibrillator | 4.8 | 7.7 |
First cardiac event*, % | 53 | 27 |
Syncope | 45 | 22 |
Aborted cardiac arrest | 2.1 | 3.0 |
Death | 5.3 | 2.4 |
Percentages >10 are rounded to a whole number. Two subjects had missing data about the date of their first cardiac event.
P<0.01.